Skip navigation

Chemical Lipids

251–300 of 9,693 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
251. 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid positive regulation of vasoconstriction 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid results in decreased positive regulation of vasoconstriction 1: Rattus norvegicus Kidney Glomerulus | Arterioles   1
252. 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid positive regulation of vasoconstriction 2-chloro-N(6)cyclopentyladenosine 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid inhibits the reaction [2-chloro-N(6)cyclopentyladenosine results in increased positive regulation of vasoconstriction] 1: Rattus norvegicus Kidney Glomerulus | Arterioles   1
253. 20-hydroxyprostaglandin E2 vasodilation 20-hydroxyprostaglandin E2 results in increased vasodilation 1: Mus musculus Basilar Artery   1
254. 20-hydroxyvitamin D2 drug metabolic process 22-hydroxycholesterol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased hydroxylation of 20-hydroxyvitamin D2 1: Bos taurus Adrenal Cortex | Mitochondria   1
255. 20-hydroxyvitamin D2 drug metabolic process 22-hydroxycholesterol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased hydroxylation of 20-hydroxyvitamin D2 1: Homo sapiens Placenta | Mitochondria   1
256. 22-hydroxycholesterol drug metabolic process 17,20-dihydroxyvitamin D2 [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased chemical synthesis of 17,20-dihydroxyvitamin D2 1: Bos taurus Adrenal Cortex | Mitochondria   1
257. 22-hydroxycholesterol drug metabolic process Ergocalciferols [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased metabolism of Ergocalciferols 1: Bos taurus Adrenal Cortex | Mitochondria   1
258. 22-hydroxycholesterol drug metabolic process 20-hydroxyvitamin D2 [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased hydroxylation of 20-hydroxyvitamin D2 1: Bos taurus Adrenal Cortex | Mitochondria   1
259. 22-hydroxycholesterol drug metabolic process 1 alpha-hydroxyergocalciferol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased hydroxylation of 1 alpha-hydroxyergocalciferol 1: Homo sapiens Placenta | Mitochondria   1
260. 22-hydroxycholesterol progesterone biosynthetic process Hydrocarbons, Chlorinated Hydrocarbons, Chlorinated inhibits the reaction [22-hydroxycholesterol results in increased progesterone biosynthetic process] 1: Mus musculus Leydig Cells | Cell Line, Tumor   1
261. 22-hydroxycholesterol drug metabolic process Ergocalciferols [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased metabolism of Ergocalciferols 1: Homo sapiens Placenta | Mitochondria   1
262. 22-hydroxycholesterol positive regulation of cholesterol metabolic process 3,5-diethoxycarbonyl-1,4-dihydrocollidine [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased positive regulation of cholesterol metabolic process] which results in increased abundance of 22-hydroxycholesterol 1: Mus musculus Liver | Multipotent Stem Cells   1
263. 22-hydroxycholesterol drug metabolic process 22-hydroxycholesterol results in decreased drug metabolic process 1: Homo sapiens Placenta | Mitochondria   1
264. 22-hydroxycholesterol drug metabolic process 1 alpha-hydroxyergocalciferol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased hydroxylation of 1 alpha-hydroxyergocalciferol 1: Bos taurus Adrenal Cortex | Mitochondria   1
265. 22-hydroxycholesterol drug metabolic process 17,20-dihydroxyvitamin D2 [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased chemical synthesis of 17,20-dihydroxyvitamin D2 1: Homo sapiens Placenta | Mitochondria   1
266. 22-hydroxycholesterol drug metabolic process 22-hydroxycholesterol results in decreased drug metabolic process 1: Bos taurus Adrenal Cortex | Mitochondria   1
267. 22-hydroxycholesterol drug metabolic process 20-hydroxyvitamin D2 [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased hydroxylation of 20-hydroxyvitamin D2 1: Homo sapiens Placenta | Mitochondria   1
268. 22-hydroxycholesterol cholesterol efflux alitretinoin | APOA1 [22-hydroxycholesterol co-treated with alitretinoin] promotes the reaction [APOA1 protein results in increased cholesterol efflux] 2: Homo sapiens | Rattus norvegicus Fetus | Astrocytes | Cells, Cultured
3 genes: ABCA1 | ABCG1 | CAV1
1
269. 22-hydroxycholesterol fatty acid transport 22-hydroxycholesterol results in increased fatty acid transport 1: Homo sapiens Hepatocytes | Cell Line   1
270. 22-hydroxycholesterol progesterone biosynthetic process 22-hydroxycholesterol results in increased progesterone biosynthetic process 1: Mus musculus Leydig Cells | Cell Line, Tumor   1
271. 22-hydroxycholesterol cholesterol efflux alitretinoin [22-hydroxycholesterol co-treated with alitretinoin] results in increased cholesterol efflux 2: Homo sapiens | Rattus norvegicus Fetus | Astrocytes | Cells, Cultured
3 genes: ABCA1 | ABCG1 | CAV1
1
272. 22-hydroxycholesterol progesterone biosynthetic process 22-hydroxycholesterol results in increased progesterone biosynthetic process 1: Rattus norvegicus Granulosa Cells | Cells, Cultured   1
273. 24,25-epoxycholesterol positive regulation of cholesterol metabolic process 3,5-diethoxycarbonyl-1,4-dihydrocollidine [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased positive regulation of cholesterol metabolic process] which results in increased abundance of 24,25-epoxycholesterol 1: Mus musculus Liver | Multipotent Stem Cells   1
274. 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine positive regulation of apoptotic process 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine results in increased positive regulation of apoptotic process 1: Mus musculus Thymocytes 1 gene: IFNG 1
275. 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine negative regulation of interferon-gamma production 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine results in increased negative regulation of interferon-gamma production 1: Mus musculus T-Lymphocytes   1
276. 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine positive regulation of apoptotic process 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine results in increased positive regulation of apoptotic process 1: Mus musculus Neurons | Tumor Cells, Cultured 1 gene: IFNG 1
277. 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine positive regulation of apoptotic process 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine results in increased positive regulation of apoptotic process 1: Mus musculus Embryo, Mammalian | Fibroblasts 1 gene: IFNG 1
278. 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine negative regulation of interleukin-17 production 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine results in increased negative regulation of interleukin-17 production 1: Mus musculus T-Lymphocytes 1 gene: IFNG 1
279. 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine negative regulation of T cell cytokine production 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine results in increased negative regulation of T cell cytokine production 1: Mus musculus T-Lymphocytes   1
280. 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine positive regulation of apoptotic process BCL2 BCL2 protein inhibits the reaction [2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine results in increased positive regulation of apoptotic process] 1: Mus musculus Thymocytes | Tumor Cells, Cultured 1 gene: IFNG 1
281. 24a-homo-1,15-dihydroxyergocalciferol positive regulation of myeloid leukocyte differentiation 24a-homo-1,15-dihydroxyergocalciferol results in increased positive regulation of myeloid leukocyte differentiation 1: Homo sapiens Myeloid Progenitor Cells | Cell Line, Tumor   1
282. 24-hydroxycholesterol positive regulation of cholesterol efflux 2-Hydroxypropyl-beta-cyclodextrin [2-Hydroxypropyl-beta-cyclodextrin results in increased positive regulation of cholesterol efflux] which results in increased secretion of 24-hydroxycholesterol 1: Homo sapiens Neural Stem Cells | Cell Line, Tumor
3 genes: ABCA1 | ABCG1 | NR1H3
1
283. 25,26-dihydroxycholecalciferol cell proliferation 25,26-dihydroxycholecalciferol results in increased cell proliferation 1: Homo sapiens Bone and Bones | Cells, Cultured   1
284. 25,26-dihydroxycholecalciferol cell proliferation 25,26-dihydroxycholecalciferol results in decreased cell proliferation 1: Homo sapiens Bone and Bones | Cells, Cultured   1
285. 25-hydroxycholesterol positive regulation of cholesterol metabolic process 3,5-diethoxycarbonyl-1,4-dihydrocollidine [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased positive regulation of cholesterol metabolic process] which results in increased abundance of 25-hydroxycholesterol 1: Mus musculus Liver | Multipotent Stem Cells   1
286. 25-hydroxycholesterol release of cytochrome c from mitochondria Acetylcysteine Acetylcysteine inhibits the reaction [25-hydroxycholesterol results in increased release of cytochrome c from mitochondria] 1: Rattus norvegicus PC12 Cells   1
287. 25-hydroxycholesterol release of cytochrome c from mitochondria Ascorbic Acid Ascorbic Acid inhibits the reaction [25-hydroxycholesterol results in increased release of cytochrome c from mitochondria] 1: Rattus norvegicus PC12 Cells   1
288. 25-hydroxycholesterol cell death 25-hydroxycholesterol results in increased cell death 1: Rattus norvegicus PC12 Cells 1 gene: CDKN1B 1
289. 25-hydroxycholesterol cell proliferation 25-hydroxycholesterol results in decreased cell proliferation 1: Homo sapiens HL-60 Cells
2 genes: INSIG1 | STAT3
1
290. 25-hydroxycholesterol apoptotic process 25-hydroxycholesterol results in increased apoptotic process 1: Homo sapiens Muscle, Smooth, Vascular | Cells, Cultured
6 genes: CASP3 | CASP8 | CASP9 | FAS | IL1B | TNFSF15
1
291. 25-hydroxycholesterol cell death 25-hydroxycholesterol results in increased cell death 1: Homo sapiens Bone Marrow | Cell Line, Tumor 1 gene: CDKN1B 1
292. 25-hydroxycholesterol release of cytochrome c from mitochondria 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [25-hydroxycholesterol results in increased release of cytochrome c from mitochondria] 1: Rattus norvegicus PC12 Cells   1
293. 25-hydroxycholesterol release of cytochrome c from mitochondria quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [25-hydroxycholesterol results in increased release of cytochrome c from mitochondria] 1: Rattus norvegicus PC12 Cells   1
294. 25-hydroxycholesterol cell death quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [25-hydroxycholesterol results in increased cell death] 1: Rattus norvegicus PC12 Cells 1 gene: CDKN1B 1
295. 25-hydroxycholesterol cell death quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [25-hydroxycholesterol results in increased cell death] 1: Homo sapiens Bone Marrow | Cell Line, Tumor 1 gene: CDKN1B 1
296. 25-hydroxycholesterol release of cytochrome c from mitochondria 25-hydroxycholesterol results in increased release of cytochrome c from mitochondria 1: Rattus norvegicus PC12 Cells   1
297. 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 positive regulation of bone mineralization Ketoconazole Ketoconazole promotes the reaction [26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 results in increased positive regulation of bone mineralization] 1: Homo sapiens Fetus | Osteoblasts | Cells, Cultured   1
298. 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 positive regulation of bone mineralization 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 results in increased positive regulation of bone mineralization 1: Homo sapiens Fetus | Osteoblasts | Cells, Cultured   1
299. 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 cell proliferation 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 results in decreased cell proliferation 1: Homo sapiens HL-60 Cells   1
300. 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 vitamin D3 metabolic process Ketoconazole [Ketoconazole results in decreased vitamin D3 metabolic process] which results in decreased metabolism of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 1: Homo sapiens Fetus | Osteoblasts | Cells, Cultured   1
251–300 of 9,693 results.